Oral Typhoid Vaccine Market, By Vaccine Type, By Age Group, By Distribution Channel, By End-User, By geography

Description

The Oral Typhoid Vaccine Market size is expected to reach US$ 888.87 Billion by 2030, from US$ 394.62 Billion in 2023, at a CAGR of 12.3% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 394.62 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	12.30%	2030 Value Projection:	US$ 888.87 Bn

Global Oral Typhoid Vaccine Market Share (%), by Region, 2023

Typhoid fever, an infectious disease caused by the bacterium Salmonella typhi, remains a significant global health concern, particularly in developing countries. With over 10 million cases reported each year, it is crucial to explore effective preventive measures, one of which is the oral typhoid vaccine

The oral typhoid vaccine, also known as Ty21a, has gained popularity due to its convenience and effectiveness in preventing typhoid fever. Unlike traditional injectable vaccines, this innovative vaccine is administered orally, making it easier to distribute and administer, especially in areas with limited healthcare facilities.

Market Dynamics:

The oral typhoid vaccine market is driven by several factors. Firstly, the increasing global incidence of typhoid fever has created a need for effective preventive measures, thereby boosting the demand for oral typhoid vaccines. Additionally, the growing awareness about the benefits of vaccination and the importance of public health initiatives has contributed to market growth.

However, there are also certain restraints to the market. One such challenge is the limited access to healthcare services in many regions, hindering the distribution and administration of oral typhoid vaccines. Moreover, the high cost associated with vaccine production and distribution poses a barrier to reaching underserved populations.

Despite these challenges, the oral typhoid vaccine market holds promising opportunities for growth. The development of cost-effective manufacturing processes and streamlined distribution networks can help overcome access barriers. Furthermore, ongoing research and development efforts to enhance the efficacy and safety of oral typhoid vaccines can drive market expansion.

Key features of the study:

This report provides in-depth analysis of the global oral typhoid vaccine market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oral typhoid vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Oral Typhoid Vaccine market include Sanofi Pasteur, Bharat Biotech, Pfizer Inc., and GlaxoSmithKline (GSK), among others
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global oral typhoid vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oral typhoid vaccine market

Detailed Segmentation:

By Vaccine Type:
- Live Attenuated Vaccine
- Inactivated Vaccine
By Age Group:
- Pediatric Vaccines
- Adult Vaccines
By Distribution Channel:
- Hospitals and Clinics
- Pharmacies and Retail Outlets
- Government Immunization Programs
By End-User:
- Travelers
- Residents of Endemic Areas
- Healthcare Workers
By Geographic Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top companies in Oral Typhoid Vaccine Market:
- Sanofi Pasteur
- Bharat Biotech
- Pfizer Inc.
- GlaxoSmithKline (GSK)
- Baxter International Inc.
- Merck & Co., Inc. (MSD outside North America)
- Takeda Pharmaceutical Company Limited
- Novartis International AG
- Biological E. Limited
- AstraZeneca
- Cipla Limited
- Prokarium
- Bio-Med Pvt. Ltd.
- Panacea Biotec
- Dynavax Technologies Corporation
- Butantan Institute
- Zydus Cadila
- Biomed Pvt. Ltd.
- Cadila Healthcare Limited
- GlaxoSmithKline Biologicals

Product Code: CMI6332

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Oral Typhoid Vaccine, By Vaccine Type
- Market Oral Typhoid Vaccine, By Age Group
- Market Oral Typhoid Vaccine, By Distribution Channel
- Market Oral Typhoid Vaccine, By End-User
- Market Oral Typhoid Vaccine, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing awareness about the benefits of vaccination
- Limited Access in Low-Income Regions
- Expanding immunization programs in developing countries
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Oral Typhoid Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Oral Typhoid Vaccine Market , By Vaccine Type, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Live Attenuated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Oral Typhoid Vaccine Market , By Age Group, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Pediatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Adult Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

7. Oral Typhoid Vaccine Market , By Distribution Channel, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Pharmacies and Retail Outlets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Government Immunization Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Oral Typhoid Vaccine Market , By End-User, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Travelers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Residents of Endemic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Healthcare Workers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Oral Typhoid Vaccine Market , By Region, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)

10. Competitive Landscape

Sanofi Pasteur
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc. (MSD outside North America)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biological E. Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Others
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us